Search research articles
Contact Us
Filters
Showing results (41-50 of 187) with videos related to
Page
of 19
Sort By:
Molecular Psychiatry
|
April 10, 2026
Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank
Eilidh Fenner, Peter Holmans, Michael C O'Donovan, et al.
Bjpsych Open
|
September 8, 2025
Associations between psychotic experience dimensions and polygenic liability to schizophrenia in a longitudinal birth cohort
Alastair G Cardno, Hein Heuvelman, Sophie E Legge, et al.
Advances in Therapy
|
September 30, 2000
Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis
P C Donshik, D Pearlman, J Pinnas, et al.
Leukemia
|
March 1, 1988
The effect of long-term marrow culture on the origin of colony-forming cells in acute myeloblastic leukemia: studies of two patients heterozygous for glucose-6-phosphate dehydrogenase
J W Singer, I D Bernstein, P C Davis, et al.
The Lancet. Psychiatry
|
May 8, 2025
Association between genetic liability to physical health conditions and comorbidities in individuals with severe mental illness: an analysis of two cross-sectional observational studies in the UK
Djenifer B Kappel, Sophie E Smart, Michael J Owen, et al.
Molecular Psychiatry
|
March 14, 2023
Family-based analysis of the contribution of rare and common genetic variants to school performance in schizophrenia
Alexandros Rammos, George Kirov, Leon Hubbard, et al.
Schizophrenia Research
|
April 7, 2020
Area deprivation, urbanicity, severe mental illness and social drift - A population-based linkage study using routinely collected primary and secondary care data
Sze Chim Lee, Marcos DelPozo-Banos, Keith Lloyd, et al.
Ebiomedicine
|
May 10, 2025
Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophrenia
Siobhan K Lock, Djenifer B Kappel, Michael J Owen, et al.
Schizophrenia Research
|
July 2, 2022
Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank
Matthew Bracher-Smith, Elliott Rees, Georgina Menzies, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 2, 2004
Clinical effectiveness in first-episode patients
Ruth I Ohlsen, Mary S O'Toole, Rick G Purvis, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 187) with videos related to
Sort By:
Page
of 19
Molecular Psychiatry
|
April 10, 2026
Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank
Eilidh Fenner, Peter Holmans, Michael C O'Donovan, et al.
Bjpsych Open
|
September 8, 2025
Associations between psychotic experience dimensions and polygenic liability to schizophrenia in a longitudinal birth cohort
Alastair G Cardno, Hein Heuvelman, Sophie E Legge, et al.
Advances in Therapy
|
September 30, 2000
Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis
P C Donshik, D Pearlman, J Pinnas, et al.
Leukemia
|
March 1, 1988
The effect of long-term marrow culture on the origin of colony-forming cells in acute myeloblastic leukemia: studies of two patients heterozygous for glucose-6-phosphate dehydrogenase
J W Singer, I D Bernstein, P C Davis, et al.
The Lancet. Psychiatry
|
May 8, 2025
Association between genetic liability to physical health conditions and comorbidities in individuals with severe mental illness: an analysis of two cross-sectional observational studies in the UK
Djenifer B Kappel, Sophie E Smart, Michael J Owen, et al.
Molecular Psychiatry
|
March 14, 2023
Family-based analysis of the contribution of rare and common genetic variants to school performance in schizophrenia
Alexandros Rammos, George Kirov, Leon Hubbard, et al.
Schizophrenia Research
|
April 7, 2020
Area deprivation, urbanicity, severe mental illness and social drift - A population-based linkage study using routinely collected primary and secondary care data
Sze Chim Lee, Marcos DelPozo-Banos, Keith Lloyd, et al.
Ebiomedicine
|
May 10, 2025
Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophrenia
Siobhan K Lock, Djenifer B Kappel, Michael J Owen, et al.
Schizophrenia Research
|
July 2, 2022
Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank
Matthew Bracher-Smith, Elliott Rees, Georgina Menzies, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 2, 2004
Clinical effectiveness in first-episode patients
Ruth I Ohlsen, Mary S O'Toole, Rick G Purvis, et al.
Page
of 19